Transactions
Innoviva, Inc.’s acquisition of La Jolla Pharmaceutical Company
Date Announced:
07/11/2022
client:
Innoviva, Inc.
Status:
Pending
Value:
$206 million
Date Announced:
07/11/2022
client:
Innoviva, Inc.
Status:
Pending
Value:
$206 million
